Targeted Covalent Inhibition of Telomerase
Overview
Biology
Affiliations
Telomerase is a ribonuceloprotein complex responsible for maintaining telomeres and protecting chromosomal integrity. The human telomerase reverse transcriptase (hTERT) is expressed in ∼90% of cancer cells where it confers the capacity for limitless proliferation. Along with its established role in telomere lengthening, telomerase also serves noncanonical extra-telomeric roles in oncogenic signaling, resistance to apoptosis, and enhanced DNA damage response. We report a new class of natural-product-inspired covalent inhibitors of telomerase that target the catalytic active site.
Kaur D, Chopra M, Saluja D Mol Divers. 2025; .
PMID: 40087255 DOI: 10.1007/s11030-025-11162-1.
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.
Shou S, Maolan A, Zhang D, Jiang X, Liu F, Li Y Exp Hematol Oncol. 2025; 14(1):8.
PMID: 39871386 PMC: 11771031. DOI: 10.1186/s40164-025-00597-9.
Prediction of mutation status in gliomas using conventional MRI radiogenomic features.
Tang C, Chen L, Xu Y, Huang L, Zeng Z Front Neurol. 2024; 15:1439598.
PMID: 39131044 PMC: 11310134. DOI: 10.3389/fneur.2024.1439598.
Liu Y, Betori R, Pagacz J, Frost G, Efimova E, Wu D Cell Chem Biol. 2022; 29(10):1517-1531.e7.
PMID: 36206753 PMC: 9588800. DOI: 10.1016/j.chembiol.2022.09.002.
Targeting telomeres: advances in telomere maintenance mechanism-specific cancer therapies.
Gao J, Pickett H Nat Rev Cancer. 2022; 22(9):515-532.
PMID: 35790854 DOI: 10.1038/s41568-022-00490-1.